BIOLASE Inc (NASDAQ:BIOL)
| 0.4111 BATS BZX Real-Time Price As of 12:58pm ET |  +0.0041 / +1.01%Today’s Change | 0.21 Today|||52-Week Range 1.46 | -25.62% Year-to-Date |
Latest BIOL News | Press Releases
| BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q2 2020 Results - Earnings Call Transcript Aug 13 / Seeking Alpha - Paid Partner Content | Biolase EPS beats by $0.05, beats on revenue Aug 13 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 0.41 |
| Today’s open | 0.41 |
| Day’s range | 0.40 - 0.42 |
| Volume | 148,290 |
| Average volume (3 months) | 7,893,256 |
| Market cap | $21.2M |
Data as of 12:58pm ET, 08/14/2020
Growth & Valuation
| Earnings growth (last year) | +26.36% |
| Earnings growth (this year) | +26.62% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -18.10% |
| P/E ratio | NM |
| Price/Sales | 0.34 |
| Price/Book | 35.06 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Williamsville Sears ... | 0.00 | 0.00% |
| PDEXPro-Dex Inc | +0.11 | +0.51% |
| MLSSMilestone Scientific... | +0.01 | +0.52% |
| ---- |
Data as of 12:44pm ET, 08/14/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $37.8M |
| Annual profit (last year) | -$17.9M |
| Net profit margin | -47.24% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
